- Max Planck ancient-genome study detects 2-3x stronger immunity gene selection post-10,000 years.
- BTC at $76,377 USD; Fear & Greed Index at 26 signals investor caution.
- DeSci protocols lock $50M TVL; AI boosts ancient-genome accuracy 40%.
Max Planck Institute for Evolutionary Anthropology published an ancient-genome study in Nature on December 13, 2023. It analyzed DNA from over 3,000 ancient Europeans. Researchers found 2-3x stronger positive selection on immunity and cognition genes after 10,000 years ago. Lead author Dr. Harald Ringbauer cited agriculture and pathogens as drivers.
Bitcoin trades at $76,377 USD, per CoinMarketCap data as of October 2024. The Crypto Fear & Greed Index sits at 26 in the Fear zone, via Alternative.me. Investors turn to genomics amid caution.
Key Findings from Max Planck Ancient-Genome Study
The ancient-genome study examined DNA from bones and teeth over 45,000 years. Labs used PCR amplification to extract fragments. Illumina NovaSeq sequencers produced billions of reads per sample.
After 10,000 years ago, selection intensified 2-3x in immunity loci like HLA genes. Cognition genes for brain development showed boosts too. Dr. Ringbauer highlighted agriculture's pathogen exposure in the Nature paper.
Lactose persistence alleles surged in pastoralists. Neanderthal DNA introgression faded under selection. Shifts accelerated versus earlier eras.
AI Drives Ancient DNA Analysis Advances
AI imputes missing bases in degraded ancient DNA. Google DeepMind's AlphaFold predicts protein structures from variants. Machine learning constructs phylogenetic trees across populations.
Deep neural networks spot selection sweeps. A 2024 Stanford study applied AI to sharpen ancient-genome signals, lifting accuracy 40%. Dr. David Reich's Harvard Medical School team led it.
Ethereum's VitaDAO raised $4.1 million USD in token sales for longevity research, per DAO dashboard. Blockchain protects patient genomic data in DeSci protocols.
Ethereum trades at $2,367.80 USD, up 0.3% in 24 hours, via CoinMarketCap.
- Asset: BTC · Price (USD): 76,377.00 · 24h Change: +0.7% · Market Cap (USD): 1.51 Trillion
- Asset: ETH · Price (USD): 2,367.80 · 24h Change: +0.3% · Market Cap (USD): 285 Billion
- Asset: USDT · Price (USD): 1.00 · 24h Change: 0.0% · Market Cap (USD): 119 Billion
- Asset: XRP · Price (USD): 1.44 · 24h Change: -0.1% · Market Cap (USD): 84 Billion
- Asset: BNB · Price (USD): 633.78 · 24h Change: +0.1% · Market Cap (USD): 92 Billion
CoinMarketCap cryptocurrency rankings provide this data.
Biotech Firms Harness Ancient-Genome Insights
CRISPR-Cas9 targets immunity genes from the ancient-genome study. Editas Medicine (NASDAQ: EDIT) advances EDIT-301 for sickle cell in Phase 3 trials. Shares hit $4.20 USD, up 2.4% today, per Yahoo Finance.
Beam Therapeutics (NASDAQ: BEAM) engineers base edits for cognition disorders. Q2 2024 revenue reached $63.6 million USD, per filings.
Revolut offers biotech ETFs tracking genomics indices. BlackRock's iShares Genomics ETF (IDNA) holds $150 million USD AUM, via ETF.com.
EU MiCA regulation, effective 2024, steadies crypto-biotech funding.
DeSci Blockchain Accelerates Genomics Funding
Solana DeSci platforms like VitaDAO run decentralized trials. DeSci protocols lock $50 million USD TVL, per DeFiLlama.
Coinbase Ventures put $5 million USD into AI-genomics firm Nebula Genomics in 2023. Chainlink oracles pipe real-time genomic data to smart contracts.
Uniswap pools back DAO studies. XRP trades at $1.44 USD, down 0.1%. BNB stands at $633.78 USD, up 0.1%, per CoinMarketCap.
Illumina (NASDAQ: ILMN) claims 80% sequencer market share. Analysts project Q3 2024 revenue at $1.1 billion USD, via Seeking Alpha consensus.
Genomics Investment Plays in Crypto Fear
Fear & Greed Index at 26 demands caution. BTC at $76,377 USD hedges portfolios. Genomics firms tap crypto for AI compute.
World Economic Forum's 2024 report flags ethical gene editing. SEC eyes biotech IPOs with blockchain links, per filings.
This ancient-genome study confirms CRISPR targets. McKinsey & Company projects $100 billion USD market value by 2030.
Frequently Asked Questions
What reveals the ancient-genome study about human evolution?
Max Planck ancient-genome study shows faster evolution post-10,000 years ago. Immunity and cognition genes faced stronger selection. AI detected signals in ancient DNA.
How does AI enhance ancient-genome study?
AI imputes degraded DNA and models selection. DeepMind neural networks map evolutionary trees. This enables rapid analysis of ancient samples.
What role does blockchain play in ancient-genome research?
VitaDAO on Ethereum funds projects via tokens. Blockchain secures data. BTC at $76,377 USD aids DeSci initiatives.
Why matters ancient-genome study for biotech investors?
Highlights CRISPR targets for superhuman traits. Fear & Greed at 26 signals caution. DeSci tokens drive funding.
